We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Napp Pharmaceuticals has launched Pelmeg in the UK, marking the group's first launch of a product developed by Cinfa Biotech, acquired by the Mundipharma network of independent associated companies in October last year.
Napp Pharmaceuticals says the UK is the first country in Europe to launch flutiform k-haler, a breath-actuate inhaler for adolescents and adults living with asthma.